Cita APA

Albisetti, M., Schlosser, A., Brueckmann, M., Gropper, S., Glund, S., Tartakovsky, I., . . . Reilly, P. A. (2017). Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Res Pract Thromb Haemost.

Citación estilo Chicago

Albisetti, Manuela, Arno Schlosser, Martina Brueckmann, Savion Gropper, Stephan Glund, Igor Tartakovsky, Leonardo R. Brandão, and Paul A. Reilly. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.

Cita MLA

Albisetti, Manuela, et al. "Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for Venous Thromboembolism." Res Pract Thromb Haemost 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.